127 related articles for article (PubMed ID: 36905694)
1. Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens.
Fenouil T; Lavrut PM; Rabeyrin M; Adham M; Mohkam K; Mabrut JY; Walter T; Hervieu V
Pathol Res Pract; 2023 Apr; 244():154406. PubMed ID: 36905694
[TBL] [Abstract][Full Text] [Related]
2. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8
Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M
Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962
[TBL] [Abstract][Full Text] [Related]
4. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
5. Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.
Kim H; Kim DH; Song IH; Youn SY; Kim B; Oh SN; Choi JI; Rha SE
Eur Radiol; 2022 Apr; 32(4):2518-2528. PubMed ID: 34671833
[TBL] [Abstract][Full Text] [Related]
6. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.
Barhli A; Cros J; Bartholin L; Neuzillet C
Dig Liver Dis; 2018 Oct; 50(10):979-990. PubMed ID: 30205952
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
Zhang LP; Ren H; Du YX; Wang CF
World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
[TBL] [Abstract][Full Text] [Related]
10. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract][Full Text] [Related]
11. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
12. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma.
Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H
BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
[TBL] [Abstract][Full Text] [Related]
17. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO
Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma.
Pergolini I; Crippa S; Pagnanelli M; Belfiori G; Pucci A; Partelli S; Rubini C; Castelli P; Zamboni G; Falconi M
BJS Open; 2019 Oct; 3(5):646-655. PubMed ID: 31592095
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transforming growth factor-β receptors in patients with pancreatic ductal adenocarcinoma.
Jiang B; Zhou L; Lu J; Wang Y; Liu C; Liang Z; Zhou W; You L; Guo J
J Gastroenterol Hepatol; 2021 Feb; 36(2):507-515. PubMed ID: 32875609
[TBL] [Abstract][Full Text] [Related]
20. Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma.
Li J; Jin L; Gao Y; Gao P; Ma L; Zhu B; Yin X; Sui S; Chen S; Jiang Z; Zhu C
J Clin Lab Anal; 2021 May; 35(5):e23742. PubMed ID: 33675071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]